Role of MUC genes and mucins in pancreatic neoplasia

American Journal of Gastroenterology

Volumn 101, Issue 10, 2006, Pages 2330-2332

  Adsay, N Volkan ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; MITOGEN ACTIVATED PROTEIN KINASE; MUCIN 1; MUCIN 2; MUCIN 4; MUCIN 6; PHOSPHATIDYLINOSITOL 3 KINASE; SMAD4 PROTEIN; TRANSCRIPTION FACTOR CDX2; TRANSFORMING GROWTH FACTOR BETA;

CELL DIFFERENTIATION; CELL GROWTH; CELL INTERACTION; CELL LINEAGE; EDITORIAL; GENE; GENE EXPRESSION; GENE FUNCTION; HUMAN; MUCIN GENE; PANCREAS TUMOR; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TANDEM REPEAT;

HUMANS; MUCINS; PANCREATIC NEOPLASMS;

EID: 33749165875     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2006.00934.x     Document Type: Editorial

References (22)

1. Andrianifahanana M, Chauhan SC, Choudhury A, et al. MUC-4 expressing adenocarcinomas show elevated levels of both TH1 and TH2 cytokines: Potential pathobiologic implications (in press). Am J Gastroenterol.
2. Andrianifahanana M, Moniaux N, Schmied BM, et al. Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: A potential role of MUC4 as a tumor marker of diagnostic significance. Clin Cancer Res 2001;7:4033-40.
3. Swartz MJ, Batra SK, Varshney GC, et al. MUC4 expression increases progressively in pancreatic intraepithelial neoplasia. Am J Clin Pathol 2002;117: 791-6.
4. Moniaux N, Junker WM, Singh AP, et al. Characterization of human mucin MUC17: Complete coding sequence and organization. J Biol Chem 2006.
5. Shibahara H, Tamada S, Higashi M, et al. MUC4 is a novel prognostic factor of intrahepatic cholangiocarcinoma-mass forming type. Hepatology 2004;39:220-9.
6. Porchet N, Aubert JP. MUC genes: Mucin or not mucin? That is the question. Med Sci (Paris) 2004;20:569-74.
7. Adsay NV, Klimstra DS. Not all "mucinous carcinomas" are equal: Time to redefine and reinvestigate the biologic significance of mucin types and patterns in the GI tract. Virchows Arch 2005;447:111-2.
8. Klöppel G, Lüttges J. WHO-classification 2000: Exocrine pancreatic tumors. Verh Dtsch Ges Pathol 2001;85:219-28.
9. Klimstra DS, Adsay NV. Benign and malignant tumors of the pancreas. In: Odze RD, Goldblum JR, Crawford JM, eds. Surgical pathology of the GI tract, liver, biliary tract and pancreas. Philadelphia, PA: Saunders, 2004: 699-731.
10. Hruban RH, Adsay NV, Albores-Saavedra J, et al. Pancreatic intraepithelial neoplasia: A new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol 2001;25:579-86.
11. Andea A, Sarkar F, Adsay VN. Clinicopathological correlates of pancreatic intraepithelial neoplasia: A comparative analysis of 82 cases with and 152 cases without pancreatic ductal adenocarcinoma. Mod Pathol 2003;16:996-1006.
12. Tanaka M, Chari S, Adsay NV, et al. International guideline for management of intraductal papillary-mucinous neoplasms and mucinous cystic neoplasms. A Consensus of the Working Group of the International Association of Pancreatology. Pancreatology 2005;6:17-32.
13. Adsay NV, Pierson C, Sarkar F, et al. Colloid (mucinous noncystic) carcinoma of the pancreas. Am J Surg Pathol 2001;25:26-42.
14. Lüttges J, Zamboni G, Longnecker D, et al. The immunohistochemical mucin expression pattern distinguishes different types of intraductal papillary mucinous neoplasms of the pancreas and determines their relationship to mucinous noncystic carcinoma and ductal adenocarcinoma. Am J Surg Pathol 2001;25:942-8.
15. Nakamura A, Horinouchi M, Goto M, et al. New classification of pancreatic intraductal papillary-mucinous tumour by mucin expression: Its relationship with potential for malignancy. J Pathol 2002;197:201-10.
16. Adsay NV, Merati K, Basturk O, et al. Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: Delineation of an "intestinal" pathway of carcinogenesis in the pancreas. Am J Surg Pathol 2004;28:839-48.
17. Adsay NV, Merati K, Nassar H, et al. Pathogenesis of colloid (pure mucinous) carcinoma of exocrine organs: Coupling of gel-forming mucin (MUC2) production with altered cell polarity and abnormal cell-stroma interaction may be the key factor in the morphogenesis and indolent behavior of colloid carcinoma in the breast and pancreas. Am J Surg Pathol 2003;27:571-8.
18. Khayyata S, Basturk O, Adsay NV et al. Invasive micropapillary carcinomas of the ampullo-pancreatobiliary region and their association with tumor infiltrating neutrophils. Mod Pathol 2005;18:1504-11.
19. Nassar H, Pansare V, Zhang H, et al. Pathogenesis of invasive micropapillary carcinoma: Role of MUC1 glycoprotein. Mod Pathol 2004;17:1045-50.
20. Yonezawa S, Taira M, Osako M, et al. MUC-1 mucin expression in invasive areas of intraductal papillary mucinous tumors of the pancreas. Pathol Int 1998;48:319-22.
21. Batra SK, Hollingsworth MA. Expression of the human mucin gene, Muc 1, in normal tissues and metastatic pancreatic tumors. Int J Pancreatol 1991;10:287-92.
22. Jonckheere N, Perrais M, Mariette C, et al. A role for human MUC4mucin gene, the ErbB2 ligand, as a target of TGF-beta in pancreatic carcinogenesis. Oncogene 2004;23:5729-38.